Happel David

President & CEO at SGMT

Sold, on record
$1.2M
Dollars the filings state
Form 4 sales
3
Latest Jul 20, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • SGMTSagimet Biosciences Inc.President & CEO

Sales by reason

0
Routine
0
Plan not stated
2
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale SGMTNo plan
    Jul 21, 2025 2025

    Sold 65,478 shares at $9.13 ($598k)

    Happel David, President & CEO

    No 10b5-1 planSold 8.7% of holdings ($6.9M position)689,722 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale SGMTNo plan
    Feb 10, 2026 +204 days

    Sold 12,101 shares at $5.36 ($65k)

    Happel David, President & CEO

    No 10b5-1 planSold 1.8% of holdings ($3.7M position)677,621 shares leftFiling

  3. 3 Form 4 sale SGMTNo plan
    Jul 20, 2026 +160 days

    Sold 64,051 shares at $7.76 ($497k)

    Happel David, President & CEO

    No 10b5-1 planSold 8% of holdings ($6.3M position)741,570 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Happel David
Source
Jul 20, 2026Jul 22, 2026SGMTPresident & CEOForm 4 sale64,051$497k8.0%No planSEC
Feb 10, 2026Feb 12, 2026SGMTPresident & CEOForm 4 sale12,101$65k1.8%No planSEC
Jul 21, 2025Jul 23, 2025SGMTPresident & CEOForm 4 sale65,478$598k8.7%No planSEC